Erik Ehinger

3PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 12, 2026
Has Glioblastoma Five- and Ten-Year Survival Been Affected by New Treatment Algorithms in Population-Based Data? A Retrospective Swedish Survey Between 1958 and 2015.

|Mar 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial.

Erik Ehinger, Anna Darabi, Edward Visse

|Feb 21, 2023
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma.

Erik Ehinger, Jan Kopecky, Anna Darabi

Pageof 1

Frequent Collaborators